header
Image from OpenLibrary

Design, synthesis and biological evaluation of some furan and furopyrimidine derivatives as novel anti-cancer agents / Manar Abdelkarim Kassem Ezz Eldin ; Supervised Safinaz Elsayed Abbas Ibrahim , Essam Eldin A. Osman , Akram Hifny Abdelhaleem

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Manar Abdelkarim Kassem Ezz Eldin , 2020Description: 143 P. : charts , facsimiles ; 25cmOther title:
  • تصميم وتشييد ودراسة النشاط البيولوجى لبعض مشتقات الفيوران والفيوروبيريميدين الجديدة كمضادات للسرطان [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry Summary: Cancer causes the rapid uncontrolled growth of abnormal cells forming a solid mass tumor or neoplasmwhich proliferates to new sites in the body causing additional tumors by a process called metastasis, patients die from metastatic spread to vital organs rather than from their primary tumors. Many types of cancer treatment are available, but there wasn't any cancer treatment can cure, shrink or stop the progression without affecting the healthy cells, so there always need for targeted cancer therapy with more precision and potentially fewer side effects.Many furans and furopyrimidine derivatives are well known to have significant anti-cancer activity through various mechanisms of action.Thus, in this study, new furan derivatives namely: 4,5-diphenyl-2-((4-(substituted) benzylidene) amino) furan-3-carbonitrile (IVa-c) and their reduced form (Va-c), 2- [(4-hydroxy-3-methoxy-5-(substitutedmethyl)benzylidene)amino]-4,5-diphenylfuran-3-carbonitrile (VIIa-d) and their reduced form(VIIIa-d), iminomethylacid hydrazide derivatives(XIIIa,b), furopyrimidines(XIb, XIVa-d) and furotriazolopyrimidines(XIa, XVa-d)were designed, synthesized and evaluated for their invitro anticancer activity at NCI, USA.The most active furan derivative VIIIcwhich exhibited a significant growth inhibition% against twenty-one cell lines ranging from 174.62-50.17% was further subjected to IC50 calculations, cellcycle analysis and apoptosis assay, in addition to enzyme inhibition assay againstBRAF and CDK2A enzymes
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.05.M.Sc.2020.Ma.D (Browse shelf(Opens below)) Not for loan 01010110082866000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.05.M.Sc.2020.Ma.D (Browse shelf(Opens below)) 82866.CD Not for loan 01020110082866000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry

Cancer causes the rapid uncontrolled growth of abnormal cells forming a solid mass tumor or neoplasmwhich proliferates to new sites in the body causing additional tumors by a process called metastasis, patients die from metastatic spread to vital organs rather than from their primary tumors. Many types of cancer treatment are available, but there wasn't any cancer treatment can cure, shrink or stop the progression without affecting the healthy cells, so there always need for targeted cancer therapy with more precision and potentially fewer side effects.Many furans and furopyrimidine derivatives are well known to have significant anti-cancer activity through various mechanisms of action.Thus, in this study, new furan derivatives namely: 4,5-diphenyl-2-((4-(substituted) benzylidene) amino) furan-3-carbonitrile (IVa-c) and their reduced form (Va-c), 2- [(4-hydroxy-3-methoxy-5-(substitutedmethyl)benzylidene)amino]-4,5-diphenylfuran-3-carbonitrile (VIIa-d) and their reduced form(VIIIa-d), iminomethylacid hydrazide derivatives(XIIIa,b), furopyrimidines(XIb, XIVa-d) and furotriazolopyrimidines(XIa, XVa-d)were designed, synthesized and evaluated for their invitro anticancer activity at NCI, USA.The most active furan derivative VIIIcwhich exhibited a significant growth inhibition% against twenty-one cell lines ranging from 174.62-50.17% was further subjected to IC50 calculations, cellcycle analysis and apoptosis assay, in addition to enzyme inhibition assay againstBRAF and CDK2A enzymes

Issued also as CD

There are no comments on this title.

to post a comment.